The Europe Neurovascular Catheters Market should witness market growth of 6.4% CAGR during the forecast period (2023-2029).
The market is experiencing growth due to the rising demand for a more natural and aesthetically pleasing appearance across all age groups, as well as a reduction in blood loss during minimally invasive surgeries. Implementing such procedures can enhance the patient experience by reducing trauma and promoting faster recovery compared to invasive procedures. Minimally invasive neurovascular procedures are expected to experience an increase in demand due to the benefits of neurovascular catheters, such as reduced blood loss and faster recovery time.
The demand for endoscopic brain surgery, which has increased as a result of the continuing advancement of endoscopic surgical procedures and single-incision laparoscopic, is a significant factor that is driving the market. Because of these improvements, conventional approaches to brain surgery will no longer be utilized, which will lead to an increase in the need for neurovascular catheters and other equipment utilized in the practice of neurovascular medicine.
The cases of the brain aneurysms in Europe are experiencing growth due to the rising incidence of neurological disorders and increased efforts in research and development to enhance product innovation for improved diagnosis. Also, the incidence of brain aneurysms is increasing in several European nations. Moreover, governments are launching strategic initiatives which are aimed at treating patients with a brain aneurysm.
In the United Kingdom, brain aneurysms affect approximately 2-3% of the population. The prevalence of this condition is higher among women than men and is more frequently observed in the adult population. The incidence rate of subarachnoid hemorrhage caused by aneurysms in the UK is estimated to be around 7 cases per 100,000 individuals with sporadic aneurysms. Thus, the growing cases of brain aneurysm in the region, with regional authorities introducing initiatives to treat, and control the disease, the utilization of neurovascular catheters are expected to increase for treatment, driving the market expansion in the region.
The Germany market dominated the Europe Neurovascular Catheters Market by Country in 2022; thereby, achieving a market value of $319.2 million by 2029. The UK market is poised to grow at a CAGR of 5.5% during (2023-2029). Additionally, The France market would showcase a CAGR of 7.2% during (2023-2029).
Based on Type, the market is segmented into Embolization Catheters, Access Catheters, Balloon Catheters, Microcatheters and Others. Based on End-Use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on Application, the market is segmented into Brain Aneurysm, Embolic Stroke, Arteriovenous Malformations and Hydrolysate. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, RAUMEDIC AG (REHAU Industries SE & Co. KG).
The market is experiencing growth due to the rising demand for a more natural and aesthetically pleasing appearance across all age groups, as well as a reduction in blood loss during minimally invasive surgeries. Implementing such procedures can enhance the patient experience by reducing trauma and promoting faster recovery compared to invasive procedures. Minimally invasive neurovascular procedures are expected to experience an increase in demand due to the benefits of neurovascular catheters, such as reduced blood loss and faster recovery time.
The demand for endoscopic brain surgery, which has increased as a result of the continuing advancement of endoscopic surgical procedures and single-incision laparoscopic, is a significant factor that is driving the market. Because of these improvements, conventional approaches to brain surgery will no longer be utilized, which will lead to an increase in the need for neurovascular catheters and other equipment utilized in the practice of neurovascular medicine.
The cases of the brain aneurysms in Europe are experiencing growth due to the rising incidence of neurological disorders and increased efforts in research and development to enhance product innovation for improved diagnosis. Also, the incidence of brain aneurysms is increasing in several European nations. Moreover, governments are launching strategic initiatives which are aimed at treating patients with a brain aneurysm.
In the United Kingdom, brain aneurysms affect approximately 2-3% of the population. The prevalence of this condition is higher among women than men and is more frequently observed in the adult population. The incidence rate of subarachnoid hemorrhage caused by aneurysms in the UK is estimated to be around 7 cases per 100,000 individuals with sporadic aneurysms. Thus, the growing cases of brain aneurysm in the region, with regional authorities introducing initiatives to treat, and control the disease, the utilization of neurovascular catheters are expected to increase for treatment, driving the market expansion in the region.
The Germany market dominated the Europe Neurovascular Catheters Market by Country in 2022; thereby, achieving a market value of $319.2 million by 2029. The UK market is poised to grow at a CAGR of 5.5% during (2023-2029). Additionally, The France market would showcase a CAGR of 7.2% during (2023-2029).
Based on Type, the market is segmented into Embolization Catheters, Access Catheters, Balloon Catheters, Microcatheters and Others. Based on End-Use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on Application, the market is segmented into Brain Aneurysm, Embolic Stroke, Arteriovenous Malformations and Hydrolysate. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, RAUMEDIC AG (REHAU Industries SE & Co. KG).
Scope of the Study
By Type
- Embolization Catheters
- Access Catheters
- Balloon Catheters
- Microcatheters
- Others
By End-use
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
By Application
- Brain Aneurysm
- Embolic Stroke
- Arteriovenous Malformations
- Hydrolysate
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Stryker Corporation
- Terumo Corporation
- Integer Holdings Corporation
- Penumbra, Inc.
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Integra LifeSciences Corporation
- Acandis GmbH
- Spiegelberg GmbH & Co. KG
- RAUMEDIC AG (REHAU Industries SE & Co. KG)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Neurovascular Catheters Market, by Type
1.4.2 Europe Neurovascular Catheters Market, by End Use
1.4.3 Europe Neurovascular Catheters Market, by Application
1.4.4 Europe Neurovascular Catheters Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Analyst's Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Trials and Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. Europe Neurovascular Catheters Market by Type
4.1 Europe Embolization Catheters Market by Country
4.2 Europe Access Catheters Market by Country
4.3 Europe Balloon Catheters Market by Country
4.4 Europe Microcatheters Market by Country
4.5 Europe Others Market by Country
Chapter 5. Europe Neurovascular Catheters Market by End-use
5.1 Europe Hospitals Market by Country
5.2 Europe Clinics Market by Country
5.3 Europe Ambulatory Surgical Centers Market by Country
5.4 Europe Diagnostic Centers Market by Country
Chapter 6. Europe Neurovascular Catheters Market by Application
6.1 Europe Brain Aneurysm Market by Country
6.2 Europe Embolic Stroke Market by Country
6.3 Europe Arteriovenous Malformations Market by Country
6.4 Europe Hydrolysate Market by Country
Chapter 7. Europe Neurovascular Catheters Market by Country
7.1 Germany Neurovascular Catheters Market
7.1.1 Germany Neurovascular Catheters Market by Type
7.1.2 Germany Neurovascular Catheters Market by End-use
7.1.3 Germany Neurovascular Catheters Market by Application
7.2 UK Neurovascular Catheters Market
7.2.1 UK Neurovascular Catheters Market by Type
7.2.2 UK Neurovascular Catheters Market by End-use
7.2.3 UK Neurovascular Catheters Market by Application
7.3 France Neurovascular Catheters Market
7.3.1 France Neurovascular Catheters Market by Type
7.3.2 France Neurovascular Catheters Market by End-use
7.3.3 France Neurovascular Catheters Market by Application
7.4 Russia Neurovascular Catheters Market
7.4.1 Russia Neurovascular Catheters Market by Type
7.4.2 Russia Neurovascular Catheters Market by End-use
7.4.3 Russia Neurovascular Catheters Market by Application
7.5 Spain Neurovascular Catheters Market
7.5.1 Spain Neurovascular Catheters Market by Type
7.5.2 Spain Neurovascular Catheters Market by End-use
7.5.3 Spain Neurovascular Catheters Market by Application
7.6 Italy Neurovascular Catheters Market
7.6.1 Italy Neurovascular Catheters Market by Type
7.6.2 Italy Neurovascular Catheters Market by End-use
7.6.3 Italy Neurovascular Catheters Market by Application
7.7 Rest of Europe Neurovascular Catheters Market
7.7.1 Rest of Europe Neurovascular Catheters Market by Type
7.7.2 Rest of Europe Neurovascular Catheters Market by End-use
7.7.3 Rest of Europe Neurovascular Catheters Market by Application
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.1.6 SWOT Analysis
8.2 Johnson & Johnson (Johnson & Johnson Services, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Penumbra, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Approvals and Trials:
8.4 Integer Holdings Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Geographical Expansions:
8.5 Terumo Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Regional Analysis
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Stryker Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Approvals and Trials:
8.6.5.2 Geographical Expansions:
8.7 Integra LifeSciences Holdings Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Acandis GmbH
8.8.1 Company Overview
8.9 Spiegelberg GmbH & Co. KG.
8.9.1 Company Overview
8.10. RAUMEDIC AG (REHAU Industries SE & Co. KG)
8.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Stryker Corporation
- Terumo Corporation
- Integer Holdings Corporation
- Penumbra, Inc.
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Integra LifeSciences Corporation
- Acandis GmbH
- Spiegelberg GmbH & Co. KG
- RAUMEDIC AG (REHAU Industries SE & Co. KG)
Methodology
LOADING...
